Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?

Gajofatto, Alberto; Bongianni, Matilde; Zanusso, Gianluigi; Benedetti, Maria Donata; Monaco, Salvatore

Gajofatto, Alberto; Bongianni, Matilde; Zanusso, Gianluigi; Benedetti, Maria Donata; Monaco, Salvatore.

Affiliation

Gajofatto A; Section of Clinical Neurology, Department of Neurological, Neuropsychological, Morphological and Motor Sciences, University of Verona, Verona 37129, Italy; E-Mail: mariadonata.benedetti@ospedaleuniverona.it.

Int J Mol Sci ; 12(11): 7960-70, 2011.

Article in En | MEDLINE | ID: mdl-22174643

Subject(s)

Biomarkers/cerebrospinal fluid; Multiple Sclerosis/cerebrospinal fluid; Multiple Sclerosis/diagnosis; 14-3-3 Proteins/cerebrospinal fluid; Cystatin C/cerebrospinal fluid; Humans; Multiple Sclerosis/pathology; Prognosis; tau Proteins/cerebrospinal fluid

Key words

14-3-3 protein; biomarkers; cystatin C; multiple sclerosis; tau protein

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers / Multiple Sclerosis Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Int J Mol Sci Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google